GSK159797 ('797) is an inhaled, longer-acting Beta2 agonist developed for the treatment of respiratory disease such as asthma and COPD.
Investigated for use/treatment in asthma and chronic obstructive pulmonary disease (COPD).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.